#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chondrosarcoma metastatic Hereditary angioedema with C1 esterase inhibitor deficiency Endocrine ophthalmopathy Vulval cancer Small cell lung cancer extensive stage Friedreich's ataxia Endometrial adenocarcinoma Ocular lymphoma Lymphatic malformation Pericarditis Immune-mediated renal disorder Gastrointestinal neuroendocrine tumour Ischaemic stroke Acquired C1 inhibitor deficiency Hodgkin's disease refractory More trials…

    Learn about Rare Diseases

    Hepatoblastoma – Diagnostics Angiosarcoma metastatic – Basic Information Turner’s syndrome – Life with Disease Primary mediastinal large B-cell lymphoma – Treatment Bronchopulmonary dysplasia – Life with Disease Undifferentiated sarcoma – Diagnostics Glycogen storage disease type V – Treatment Systemic mastocytosis – Diagnostics Cerebral arteriovenous malformation haemorrhagic – Basic Information Synovial sarcoma metastatic – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Clofutriben Diclofenac Diethylamine Galcanezumab Omp64 Cln-081 His203-Crm197 Imipenem Anhydrate Risedronate Sodium Alternaria Alternata (402) A52 Teropavimab Cenobamate Immunostimulants Pf-06835375 Water For Injection ZILEBESIRAN CHLOROQUINE PHOSPHATE 99MTC-EUK-(SO3)CY5-MAS3 Ciltacabtagene Autoleucel HYDROMORPHONE HYDROCHLORIDE More therapies…

    Learn about Your Condition

    Retroperitoneal cancer Migraine without aura Colitis Atrial septal defect Acoustic neuroma Pertussis Measles Peripheral spondyloarthritis Neuroblastoma Conjunctivitis Alveolar rhabdomyosarcoma Neonatal asphyxia Systemic candida Meniscus operation Mucopolysaccharidosis I More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Parkinson’s disease

  • Efficacy of intravenous prasinezumab versus placebo in Parkinson’s disease patients with severe GBA mutation: a 104‑week randomized double‑blind study

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Prasinezumab
    • Sodium Chloride
    France Germany Italy Luxembourg Spain Sweden

  • Cognitive effects of a three‑month methylphenidate course in Parkinson’s disease patients with mild cognitive impairment

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Methylphenidate Hydrochloride
    Spain

  • Montelukast Sodium for disease-modifying treatment in patients with mild‑moderate Parkinson’s disease: open‑label phase II extension study

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Montelukast Sodium
    Sweden

  • Safety, CNS penetration and target engagement of Mirivadelgat in participants with Parkinson’s disease

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Parkinson’s disease
    Norway

  • A study to optimize the delivery of AAV2-GDNF and gadoteridol into the brain for patients with Parkinson’s disease

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Adeno-Associated Viral Vector Serotype 2 Encoding Glial Cell Line-Derived Neurotrophic Factor
    • Gadoteridol
    Poland

  • Long-term safety and effectiveness follow-up study of AB-1005 gene therapy in patients with Parkinson’s disease or multiple system atrophy

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Multiple system atrophy
    • Parkinson’s disease
    Investigated Drugs:
    • Adeno-Associated Viral Vector Serotype 2 Encoding Glial Cell Line-Derived Neurotrophic Factor
    • Carbidopa
    • Fluorodopa (18F)
    Poland
Previous Page
1 2 3 4 5 6 … 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!